Seawolf Therapeutics
LNP-delivered DNA medicines (Trident platform)
Seawolf Therapeutics (San Diego, United States) — lNP-delivered DNA medicines (Trident platform). On November 16, 2026 it announced a $100M Seed + Series A (stealth launch), led by Versant Ventures. Launched alongside a Sanofi research pact worth up to $1.2B in milestones.
Biotech
📍 San Diego
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Seawolf Therapeutics going public?
No. Seawolf Therapeutics is private and has not filed to go public. There is no S-1 on file.
What is Seawolf Therapeutics' valuation in 2026?
No confirmed valuation is on record for Seawolf Therapeutics. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Seawolf Therapeutics filed an S-1?
No public S-1 is on file for Seawolf Therapeutics.
Who are Seawolf Therapeutics' investors?
Seawolf Therapeutics' investors include Versant Ventures, MPM BioImpact, Novartis Venture Fund, Eli Lilly, CRISPR Therapeutics, Sixty Degree Capital and 2 more.
How much has Seawolf Therapeutics raised?
Seawolf Therapeutics has raised $100M in total across 1 disclosed round, most recently a Seed + Series A (stealth launch) of $100M in Nov 2026.
Is Seawolf Therapeutics publicly traded — can you buy Seawolf Therapeutics stock?
No. Seawolf Therapeutics is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Seawolf Therapeutics on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Last Round
Seed + Series A (stealth launch) — $100M (Nov 2026) · Lead: Versant Ventures
Fundraising Status
Seed + Series A (stealth launch) · $100M · this month
privateTotal raised $100M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Seed + Series A (stealth launch) | $100M | Nov 2026 | Versant Ventures | — |
Recent Activity
💰Nov 2026 · Fierce Biotech · funding
Vertical Intelligence — Biotech / Gene Therapy
Biotech / Gene Therapy registry data for Seawolf Therapeutics has not been collected yet — the weekly vertical sweep hasn't reached this company. Check back soon.
Talent Signal
Hiring data for Seawolf Therapeutics has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
Investors
Versant Ventures · MPM BioImpact · Novartis Venture Fund · Eli Lilly · CRISPR Therapeutics · Sixty Degree Capital · Alexandria Venture Investments · Pathway to Cures
BiotechLNP-delivered DNA medicines
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.